Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Pushing the Right Buttons
Improving Efficacy of Therapeutic DNA Vectors
Single-Cell Cloning Remains a Challenge
Evolving Technologies Help Make It Easier to Meet Regulatory Requirements
Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
For full access to this article login to GEN Select now.
Discovery of Functional Serum Biomarkers
Exploring Cancer’s Signature in the Sensitive Functional Domain of the Human Proteome
- Lung cancer is one of the most common malignancies and the leading cause of cancer-related fatality. In the U.S. alone, more than 210,000 new lung cancer cases are diagnosed every year, with more than 170,000 deaths resulting from the disease each year. Current diagnostic practices for common cancers ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.